Registro:

Referencias:

• Albani, C.M., Elissondo, M.C., Cumino, A.C., Chisari, A., Denegri, G.M., Primary cell culture of Echinococcus granulosus developed from the cystic germinal layer: biological and functional characterization (2010) Int. J. Parasitol., 40, pp. 1269-1275
• Ayres, M., Ayres, M., Ayres, D.L., Santos, A.S., (2007) BioEstat 5.0 aplicações estatísticas nas áreas das ciências biomédicas, , Imprensa Oficial do Estado do Pará, Brazil
• Blagosklonny, M.V., Fojo, T., Molecular effects of paclitaxel: myths and reality (a critical review) (1999) Int. J. Cancer, 83, pp. 151-156
• Brunetti, E., Garcia, H.H., Junghanss, T., Cystic echinococcosis: chronic, complex, and still neglected (2011) PLoS Negl. Trop. Dis., 5 (7), pp. e1146
• Budke, C.M., Carabin, H., Ndimubanzi, P.C., Nguyen, H., Rainwater, E., Dickey, M., Bhattarai, R., Qian, M.B., A Systematic review of the literature on cystic echinococcosis frequency worldwide and its associated clinical manifestations (2013) Am. J. Trop. Med. Hyg., 88, pp. 1011-1027
• Bygott, J.M., Chiodini, P.L., Praziquantel: Neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease? (2009) Acta Trop., 111, pp. 95-101
• Calabro-Jones, P.M., Byfield, J.E., Ward, J.F., Sharp, T.R., Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro (1982) Cancer Res., 42, pp. 4413-4420
• Casado, N., Moreno, M., Urrea-París, M., Rodríguez-Caabeiro, F., Could ivermectin have a synergic effect with albendazole in hydatidosis therapy? In vitro studies (2002) Parasitol. Res., 88, pp. 153-159
• Ceballos, L., Elissondo, M.C., Moreno, L., Dopchiz, M., Sánchez Bruni, S., Denegri, G., Alvarez, L., Lanusse, C., Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations (2008) Parasitol. Res., 103, pp. 355-362
• Elissondo, M.C., Ceballos, L., Alvarez, L., Sánchez Bruni, S., Lanusse, C., Denegri, G., Flubendazole and ivermectin in vitro combination therapy produces a marked effect on Echinococcus granulosus protoscoleces and metacestodes (2009) Parasitol. Res., 105, pp. 835-842
• Elissondo, M.C., Ceballos, L., Dopchiz, M., Andresiuk, V., Alvarez, L., Sánchez Bruni, S., Lanusse, C., Denegri, G., In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes (2007) Parasitol. Res., 100, pp. 1003-1009
• Elissondo, M.C., Dopchiz, M., Ceballos, L., Alvarez, L., Sánchez Bruni, S., Lanusse, C., Denegri, G., In vitro effects of flubendazole on Echinococcus granulosus protoscoleces (2006) Parasitol. Res., 98, pp. 317-323
• Estes, R., Vogel, N., Mack, D., McLeod, R., Paclitaxel arrests growth of intracellular Toxoplasma gondii (1998) Antimicrob. Agents Chemother., 42, pp. 2036-2040
• Galindo, M., Schadebrodt, G., Galanti, N., Echinococcus granulosus: cellular territories and morphological regions in mature protoscoleces (2008) Exp. Parasitol., 199, pp. 524-533
• Grem, J.L., McAtee, N., Steinberg, S.M., Hamilton, J.M., Murphy, R.F., Drake, J., Chisena, T., Allegra, C.J., A Phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-l-aspartate in metastatic gastrointestinal adenocarcinoma (1993) Cancer Res., 53, pp. 4828-4836
• Harris, B.E., Song, R., Soong, S.J., Diasio, R.B., Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion (1990) Cancer Res., 50, pp. 197-201
• Heidelberger, C., Chaudhuari, N.K., Daneberg, P., Mooreh, D., Griesbach, L., Duschinsky, K., Schnitzer, R.J., Pleven, E., Fluorinated pyrimidines. A new class of tumor inhibitory compounds (1957) Nature, 179, pp. 663-666
• Hemer, S., Brehm, K., In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae (2012) Int. J. Antimicrob. Agents, 40, pp. 458-462
• Hemphill, A., Müller, J., Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options (2009) J. Helminthol., 83, pp. 99-111
• Hemphill, A., Spicher, M., Stadelmann, B., Mueller, J., Naguleswaran, A., Gottstein, B., Walker, M., Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis (2007) Parasitology, 134, pp. 1657-1670
• Huizing, M.T., Sewberath Misser, V.H., Pieters, R.C., ten Bokkel Huinink, W.W., Veenhof, C.H.N., Vermorken, J.B., Pinedo, H.M., Beijnen, J.H., Taxanes: a new class of antitumor agents (1995) Cancer Invest., 13, pp. 381-404
• Hübner, C., Wiehr, S., Kocherscheidt, L., Wehrl, H., Pichler, B.J., Schmid, A., Kern, P., Soboslay, P.T., Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite (2010) Parasitol. Res., 107, pp. 459-463
• Klinkert, M.Q., Heussler, V., The use of anticancer drugs in antiparasitic chemotherapy (2006) Mini Rev. Med. Chem., 6, pp. 131-143
• Küster, T., Lense, N., Barna, F., Hemphill, A., Kindermann, M.K., Heinicke, J.W., Vock, C.A., A new promising application for highly cytotoxic metal compounds: η6-areneruthenium(II) phosphite complexes for the treatment of alveolar echinococcosis (2012) J. Med. Chem., 55, pp. 4178-4188
• Liance, M., Nemati, F., Bories, C., Couvreur, P., Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liver (1993) Int. J. Parasitol., 23, pp. 427-429
• Longley, D.B., Harkin, D.P., Johnston, P.G., 5-Fluorouracil: mechanisms of action and clinical strategies (2003) Nat. Rev. Cancer, 3, pp. 330-338
• McManus, D.P., Gray, D.J., Zhang, W., Yang, Y., Diagnosis, treatment, and management of echinococcosis (2012) Br. J. Med. Med. Res., 344, pp. 39-44
• Moro, P., Schantz, P.M., Echinococcosis: a review (2009) Int. J. Infec. Dis., 13, pp. 125-133
• Naguleswaran, A., Spicher, M., Vonlaufen, N., Ortega-Mora, L.M., Torgerson, P., Gottstein, B., Hemphill, A., In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus (2006) Antimicrob. Agents Chemother., 50, pp. 3770-3778
• NgÔ, C., Nicco, C., Leconte, M., Chéreau, C., Weill, B., Batteux, F., Chapron, C., Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo (2010) Fertil. Steril., 94, pp. 1632-1638
• Pawlowski, Z.S., Eckert, J., Vuitton, D.A., Ammann, R.W., Kern, P., Craig, P.S., Dar, K.F., Wen, H., Echinococcosis in humans: clinical aspects, diagnosis and treatment (2001) WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern, pp. 20-66. , World Organisation for Animal Health, Paris, France, J. Eckert, M.A. Gemmell, F.X. Meslin, Z.S. Pawlowski (Eds.)
• Pérez-Serrano, J., Casado, N., Denegri, G., Rodríguez-Caabeiro, F., The effects of albendazole and albendazole sulphoxide combination-therapy on Echinococcus granulosus in vitro (1994) Int. J. Parasitol., 24, pp. 219-224
• Pouvelle, B., Farley, P.J., Long, C.A., Taraschi, T.F., Taxol arrests the development of blood-stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice (1994) J. Clin. Invest., 94, pp. 413-417
• Rathod, P.K., Khatri, A., Hubbert, T., Milhous, W.K., Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro (1989) Antimicrob. Agents Chemother., 33, pp. 1090-1094
• Rowinsky, E.K., Donerhower, R.C., Paclitaxel (taxol) (1995) N. Engl. J. Med., 332, pp. 1004-1014
• Rowinsky, E.K., Donehower, R.C., Jones, R.J., Tucker, R.W., Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol (1988) Cancer Res., 48, pp. 4093-4100
• Rutman, R.J., Cantarow, A., Paschkis, K.E., Studies on 2-acetylaminofluorene carcinogenesis: III. The utilization of uracil-2-C14 by pre-neoplastic rat liver (1954) Cancer Res., 14, pp. 119-123
• Spicher, M., Naguleswaran, A., Ortega-Mora, L.M., Müller, J., Gottstein, B., Hemphill, A., In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes (2008) Exp. Parasitol., 119, pp. 475-482
• Spicher, M., Roethlisberger, C., Lany, C., Stadelmann, B., Keiser, J., Ortega-Mora, L.M., Gottstein, B., Hemphill, A., In vitro and in vivo treatments of Echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives (2008) Antimicrob. Agents Chemother., 52, pp. 3447-3450
• Stamatakos, M., Sargedi, C., Stefanaki, C., Safioleas, C., Matthaiopoulou, I., Safioleas, M., Anthelminthic treatment: an adjuvant therapeutic strategy against Echinococcus granulosus (2009) Parasitol. Int., 58, pp. 115-120
• Stojkovic, M., Zwahlen, M., Teggi, A., Vutova, K., Cretu, C.M., Virdone, R., Nicolaidou, P., Junghanss, T., Treatment response of cystic echinococcosis to benzimidazoles: a systematic review (2009) PLoS Negl. Trop. Dis., 3, pp. e524
• Urrea-Paris, M., Moreno, M., Casado, N., Rodriguez-Caabeiro, F., Echinococcus granulosus: praziquantel treatment against the metacestode stage (1999) Parasitol. Res., 85, pp. 999-1006
• Urrea-Paris, M., Moreno, M., Casado, N., Rodríguez-Caabeiro, F., In vitro effect of praziquante and albendazole combination therapy of the larval stage of Echinococcus granulosus (2000) Parasitol. Res., 86, pp. 957-964
• Walker, M., Rossignol, J., Torgerson, P., Hemphill, A., In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes (2004) J. Antimicrob. Chemother., 54, pp. 609-616
• Wani, M., Taylor, H.L., Wall, M.E., Plant antitumor agents VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia (1971) J. Am. Chem. Soc., 93, pp. 2325-2327
• Zheng, H., Zhang, W., Zhang, L., Zhang, Z., Li, J., Lu, G., Zhu, Y., Wang, Y.S., The genome of the hydatid tapeworm Echinococcus granulosus (2013) Nat. Genet., 45, pp. 1168-1175

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------